Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
national top stories
novartis
5
×
san francisco top stories
boston blog main
boston top stories
national
new york top stories
roche
san francisco blog main
amgen
biogen
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
medicare
merck
new york blog main
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
cancer
diagnostics
What
patients
5
×
bio
drug
roundup
new
therapy
acquisitions
advantages
albert
analytics
approved
atrophy
bar
becker
biggest
billions
biofourmis
bourla
brings
ceo
company
crispr
daily
data
devices
digital
dollars
eaton
employs
evrysdi
expect
fda
friday
future
gamble
gene
globally
green
hauls
healthcare
Language
unset
unknown
Current search:
patients
×
biotech
×
novartis
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More